Bio & Pharmaceuticals

Article | March 31, 2004
New York: A Growth Area for Technology Firms   

A skilled and sophisticated workforce and world-class businesses make New York State a national leader in high-technology, with more than $7.4... More>>


Development News | January 29, 2004
Telerx Chooses Penticton as Site for New Contact Center   

Telerx, a leading outsource partner that provides world-class customer care services, has chosen Penticton as the location for its fifth customer... More>>


Article | December 31, 2003
North Carolina Soars with Success   

Equipped with new, flexible incentives, a well-skilled workforce and one of the nation’s lowest corporate tax costs, North Carolina continues to... More>>


Development News | December 10, 2003
Merck Offered $36.2MM Incentive Package from State   

With incentives in hand, Merck & Co. is expected to decide over the next sevarl weeks whether to build its $300MM plant in Durham. More>>


Development News | November 19, 2003
Biotech in Crosshairs   

New Workforce Development program in NC focusing in Bio industries. To read more, click below. More>>


Article | June 30, 2003
The Bioscience Industry of Georgia   

Georgia is home to a growing bioscience cluster and the state has taken an active role in ensuring the success of the industry. Georgia’s focus is... More>>


Article | June 30, 2003
Virginia: A Top Choice for Bioscience Companies   

For nearly 400 years, the Commonwealth of Virginia has long supported business prosperity, dating back to Jamestown, the first permanent English... More>>


Article | June 30, 2003
New York: The Future of Pharmaceuticals   

New York’s pharmaceutical industry has nourished the state’s economy by bringing thousands of jobs and billions of dollars worth of investment.... More>>


Article | June 30, 2003
Reach the World From Kentucky   

In addition to the location and access that makes Kentucky an ideal spot for the logistics industry – or any business – Kentucky is also... More>>


Article | June 30, 2003
Reaching Biotech's Critical Mass   

After more than two years of a down market, it's definitely looking like the biotech industry is beginning to see the light at the end of the tunnel. More>>